United Kingdom · Delayed Price · Currency is GBP · Price in GBX Abingdon Health Statistics
Total Valuation
Abingdon Health has a market cap or net worth of GBP 39.16 million. The enterprise value is 37.63 million.
| Market Cap | 39.16M |
| Enterprise Value | 37.63M |
Important Dates
The last earnings date was Tuesday, October 13, 2026.
| Earnings Date | Oct 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Abingdon Health has 435.07 million shares outstanding. The number of shares has increased by 12.97% in one year.
| Current Share Class | 252.75M |
| Shares Outstanding | 435.07M |
| Shares Change (YoY) | +12.97% |
| Shares Change (QoQ) | +9.72% |
| Owned by Insiders (%) | 6.36% |
| Owned by Institutions (%) | 29.79% |
| Float | 169.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.56 |
| PB Ratio | 6.41 |
| P/TBV Ratio | 11.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.91 |
| Quick Ratio | 1.71 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -65.88 |
Financial Efficiency
Return on equity (ROE) is -37.32% and return on invested capital (ROIC) is -25.71%.
| Return on Equity (ROE) | -37.32% |
| Return on Assets (ROA) | -17.60% |
| Return on Invested Capital (ROIC) | -25.71% |
| Return on Capital Employed (ROCE) | -39.60% |
| Weighted Average Cost of Capital (WACC) | 4.44% |
| Revenue Per Employee | 83,916 |
| Profits Per Employee | -16,244 |
| Employee Count | 131 |
| Asset Turnover | 1.09 |
| Inventory Turnover | 9.22 |
Taxes
In the past 12 months, Abingdon Health has paid 106,000 in taxes.
| Income Tax | 106,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.00% in the last 52 weeks. The beta is 0.05, so Abingdon Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | +44.00% |
| 50-Day Moving Average | 10.45 |
| 200-Day Moving Average | 9.43 |
| Relative Strength Index (RSI) | 14.25 |
| Average Volume (20 Days) | 132,010 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Abingdon Health had revenue of GBP 10.99 million and -2.13 million in losses. Loss per share was -0.01.
| Revenue | 10.99M |
| Gross Profit | 5.18M |
| Operating Income | -2.83M |
| Pretax Income | -2.02M |
| Net Income | -2.13M |
| EBITDA | -2.32M |
| EBIT | -2.83M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 2.87 million in cash and 1.34 million in debt, with a net cash position of 1.52 million or 0.00 per share.
| Cash & Cash Equivalents | 2.87M |
| Total Debt | 1.34M |
| Net Cash | 1.52M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 6.10M |
| Book Value Per Share | 0.01 |
| Working Capital | 3.34M |
Cash Flow
In the last 12 months, operating cash flow was -1.61 million and capital expenditures -190,000, giving a free cash flow of -1.80 million.
| Operating Cash Flow | -1.61M |
| Capital Expenditures | -190,000 |
| Depreciation & Amortization | 511,000 |
| Net Borrowing | -230,000 |
| Free Cash Flow | -1.80M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 47.10%, with operating and profit margins of -25.77% and -19.36%.
| Gross Margin | 47.10% |
| Operating Margin | -25.77% |
| Pretax Margin | -18.39% |
| Profit Margin | -19.36% |
| EBITDA Margin | -21.12% |
| EBIT Margin | -25.77% |
| FCF Margin | n/a |
Dividends & Yields
Abingdon Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -12.97% |
| Shareholder Yield | -12.97% |
| Earnings Yield | -5.71% |
| FCF Yield | -4.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Abingdon Health has an Altman Z-Score of 0.07 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.07 |
| Piotroski F-Score | 4 |